Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study ; volume:33 ; number:5 ; day:15 ; month:1 ; year:2022 ; pages:1155-1164 ; date:5.2022
Osteoporosis international ; 33, Heft 5 (15.1.2022), 1155-1164, 5.2022
- Urheber
-
Lai, E. C.-C
Lin, T.-C
Lange, J. L.
Chen, L.
Wong, I. C. K.
Sing, C.-W
Cheung, C.-L
Shao, S.-C
Yang, Y.-H. Kao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00198-021-06291-w
- URN
-
urn:nbn:de:101:1-2022062822171729129342
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lai, E. C.-C
- Lin, T.-C
- Lange, J. L.
- Chen, L.
- Wong, I. C. K.
- Sing, C.-W
- Cheung, C.-L
- Shao, S.-C
- Yang, Y.-H. Kao
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
Postmenopausal osteoporosis
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Real-world treatment and fracture incidence in postmenopausal women with severe osteoporosis at high risk of fracture: a retrospective claims data analysis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
Postmenopausal osteoporosis
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Real-world treatment and fracture incidence in postmenopausal women with severe osteoporosis at high risk of fracture: a retrospective claims data analysis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
Postmenopausal osteoporosis
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Real-world treatment and fracture incidence in postmenopausal women with severe osteoporosis at high risk of fracture: a retrospective claims data analysis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide